Arcosa, Inc. Common Stock vs. INNOVATE Corp.
Arcosa, Inc. Common Stock and INNOVATE Corp. are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ACA | VATE | |
|---|---|---|
| Market Cap | $7.11 billion | $165.20 million |
| Revenue (TTM) | $2.74 billion | — |
| Net Income (TTM) | $491.40 million | — |
ACA leads on 1 of 1 size & scale factors.
Valuation
| ACA | VATE | |
|---|---|---|
| P/E Ratio | 14.53 | — |
| Price / Book | 2.38 | — |
| Price / Sales | 2.59 | — |
ACA and VATE split the valuation factors evenly.
Profitability
| ACA | VATE | |
|---|---|---|
| Net Margin | 17.90% | — |
| Return on Equity | 16.47% | — |
ACA and VATE split the profitability factors evenly.
Dividend
| ACA | VATE | |
|---|---|---|
| Dividend Yield | 0.14% | — |
| Payout Ratio | 2.01 | — |
ACA and VATE split the dividend factors evenly.
Risk & Sentiment
| ACA | VATE | |
|---|---|---|
| Short Interest | 2.16% | 1.03% |
VATE leads on 1 of 1 risk & sentiment factors.
Dig deeper: ACA overview, ACA financials, VATE overview, VATE financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.